Hologic Posts Solid 4Q but Guides Below Expectations for 2013; Shares Remain...
Hologic HOLX posted fourth-quarter results in line with our expectations, but its conservative outlook for 2013 was disappointing. While we think the company is taking an overly conservative stance...
View ArticleHologic Kicks Off Fiscal 2013 With Solid 1Q, and We're Raising Our Fair Value...
Hologic HOLX posted fiscal first-quarter results largely in line with our expectations. We are encouraged by the strong operational performance, particularly in light of adverse conditions for capital...
View ArticleHologic to Strengthen Diagnostics Capabilities Through Gen-Probe Acquisition
Gen-Probe GPRO announced that it has received a takeover offer from Hologic HOLX for $82.75 per share, representing a total enterprise value of approximately $3.7 billion. The offer represents a 20%...
View ArticleFindings From Oslo Breast Cancer Screening Trial a Key Win for Hologic
Our fair value estimate for Hologic HOLX is unchanged following the publication of favorable results from a large screening trial for the use of digital mammography combined with 3-D tomosynthesis....
View ArticleHologic Announces Sale of LIFECODES
On Thursday, Hologic HOLX announced that it has reached a final agreement to sell its LIFECODES business (acquired through the Gen-Probe transaction) to Immucor for $85 million in cash and a possible...
View ArticleHologic Reports Solid 2Q but Issues Disappointing Outlook; Plan to Lower Fair...
Hologic HOLX posted second-quarter results mostly in line with our expectations on Monday as lower-than-expected revenue was offset by solid expense management. We were encouraged by the company's...
View ArticleHologic to Buy Third Wave
On Monday, Hologic HOLX announced the acquisition of Third Wave Technologies TWTI, a developer of molecular diagnostic screens, for $580 million, or $11.25 per share. At first glance, the purchase...
View ArticleStrong First Quarter Marks Hologic's Fiscal 2012 Kickoff
Hologic HOLX posted better-than-expected fiscal first-quarter operating results Monday, highlighting improved performance across all four business segments. While we are pleased with this progress, we...
View ArticleHologic Trims Guidance Again; 3D Dimensions' Prospects Rely on Favorable...
Hologic HOLX reported third-quarter results Monday that fell in line with our previous expectations, with light revenue growth and adequate expense management. The company lowered its guidance as newly...
View ArticleUpdate on Cytyc-Hologic Merger
We anticipate the merger between Cytyc CYTC and Hologic HOLX will close as scheduled in the third quarter, despite the tightening credit environment. We're maintaining our fair value estimate for...
View Article
More Pages to Explore .....